Literature DB >> 18542790

Renal cell carcinoma: currently the most interesting genitourinary malignancy.

Lori A Wood1, Michael A S Jewett.   

Abstract

Entities:  

Year:  2007        PMID: 18542790      PMCID: PMC2422952          DOI: 10.5489/cuaj.72

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  6 in total

1.  Laparoscopic nephrectomy: initial case report.

Authors:  R V Clayman; L R Kavoussi; N J Soper; S M Dierks; S Meretyk; M D Darcy; F D Roemer; E D Pingleton; P G Thomson; S R Long
Journal:  J Urol       Date:  1991-08       Impact factor: 7.450

2.  The results of radical nephrectomy for renal cell carcinoma.

Authors:  C J Robson; B M Churchill; W Anderson
Journal:  J Urol       Date:  1969-03       Impact factor: 7.450

3.  Molecular correlates of imatinib resistance in gastrointestinal stromal tumors.

Authors:  Michael C Heinrich; Christopher L Corless; Charles D Blanke; George D Demetri; Heikki Joensuu; Peter J Roberts; Burton L Eisenberg; Margaret von Mehren; Christopher D M Fletcher; Katrin Sandau; Karen McDougall; Wen-bin Ou; Chang-Jie Chen; Jonathan A Fletcher
Journal:  J Clin Oncol       Date:  2006-09-05       Impact factor: 44.544

Review 4.  Imatinib-refractory gastrointestinal stromal tumors: the clinical problem and therapeutic strategies.

Authors:  Margaret von Mehren
Journal:  Curr Oncol Rep       Date:  2006-05       Impact factor: 5.075

Review 5.  Laparoscopic and partial nephrectomy.

Authors:  Andrew C Novick
Journal:  Clin Cancer Res       Date:  2004-09-15       Impact factor: 12.531

6.  Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

Authors:  Herbert Hurwitz; Louis Fehrenbacher; William Novotny; Thomas Cartwright; John Hainsworth; William Heim; Jordan Berlin; Ari Baron; Susan Griffing; Eric Holmgren; Napoleone Ferrara; Gwen Fyfe; Beth Rogers; Robert Ross; Fairooz Kabbinavar
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.